DIFFUSE INTERMYOCARDIOCYTIC FIBROSIS IN UREMIC PATIENTS

被引:252
作者
MALL, G
HUTHER, W
SCHNEIDER, J
LUNDIN, P
RITZ, E
机构
[1] UNIV HEIDELBERG,DEPT INTERNAL MED,W-6900 HEIDELBERG,GERMANY
[2] UNIV ZURICH,DEPT PATHOL,CH-8006 ZURICH,SWITZERLAND
关键词
Cardiomyopathy; Diabetes mellitus; Haemodialysis; Hypertension; Intermyocardiocytic fibrosis; Uraemia;
D O I
10.1093/ndt/5.1.39
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
At post-mortem we examined heart tissue of (i) 31 patients with uraemia not on dialysis, (ii) 42 patients on haemodialysis for less than 6 months, (iii) 60 patients on haemodialysis for more than 6 months, (iv) 16 patients after renal transplantation, and (v) 11 patients on CAPD. Patients with stenosing coronary lesions were excluded. Diffuse non-coronary intermyocardiocytic fibrosis, assessed by a score system in trichrome-stained sections, was found in 91% of chronically uraemic patients, but not in non-hypertensive, non-diabetic controls. The lesion was present even in non-dialysed uraemic patients; in dialysed patients its severity was related to the duration of dialysis; it was demonstrable even years after renal transplantation. On electron-microscopy, collagen fibres were seen, while rβ2-M amyloid was consistently absent. Logistic regression analysis showed that uraemia was a determinant of intermyocardiocytic fibrosis independent of hypertension, diabetes mellitus, anaemia, heart weight, and presence or absence of dialysis procedure. © 1990 European Dialysis and Transplant Association-European Renal Association.
引用
收藏
页码:39 / 44
页数:6
相关论文
共 16 条
[1]  
Bright R., 1836, GUYS HOSP REP, V1, P380
[2]  
HARRELL F, 1986, SAS SUPPLEMENTAL LIB, P181
[3]   DIASTOLIC STIFFNESS AND MYOCARDIAL STRUCTURE IN AORTIC-VALVE DISEASE BEFORE AND AFTER VALVE-REPLACEMENT [J].
HESS, OM ;
RITTER, M ;
SCHNEIDER, J ;
GRIMM, J ;
TURINA, M ;
KRAYENBUEHL, HP .
CIRCULATION, 1984, 69 (05) :855-865
[4]  
JANSEN H H, 1962, Verh Dtsch Ges Pathol, V46, P262
[5]  
KRAMER W, 1985, MED WELT, V36, P1228
[6]   LEFT-VENTRICULAR MYOCARDIAL STRUCTURE IN AORTIC-VALVE DISEASE BEFORE, INTERMEDIATE, AND LATE AFTER AORTIC-VALVE REPLACEMENT [J].
KRAYENBUEHL, HP ;
HESS, OM ;
MONRAD, ES ;
SCHNEIDER, J ;
MALL, G ;
TURINA, M .
CIRCULATION, 1989, 79 (04) :744-755
[7]   UREMIC CARDIOMYOPATHY - AN INADEQUATE LEFT-VENTRICULAR HYPERTROPHY [J].
LONDON, GM ;
FABIANI, F ;
MARCHAIS, SJ ;
DEVERNEJOUL, MC ;
GUERIN, AP ;
SAFAR, ME ;
METIVIER, F ;
LLACH, F .
KIDNEY INTERNATIONAL, 1987, 31 (04) :973-980
[8]   MYOCARDIAL INTERSTITIAL FIBROSIS IN EXPERIMENTAL UREMIA - IMPLICATIONS FOR CARDIAC COMPLIANCE [J].
MALL, G ;
RAMBAUSEK, M ;
NEUMEISTER, A ;
KOLLMAR, S ;
VETTERLEIN, F ;
RITZ, E .
KIDNEY INTERNATIONAL, 1988, 33 (04) :804-811
[9]   CLINICOPATHOLOGIC CORRELATIONS IN CONGESTIVE CARDIOMYOPATHY - A STUDY ON ENDOMYOCARDIAL BIOPSIES [J].
MALL, G ;
SCHWARZ, F ;
DERKS, H .
VIRCHOWS ARCHIV A-PATHOLOGICAL ANATOMY AND HISTOPATHOLOGY, 1982, 397 (01) :67-82
[10]   CASE FOR A SPECIFIC UREMIC MYOCARDOPATHY [J].
PROSSER, D ;
PARSONS, V .
NEPHRON, 1975, 15 (01) :4-7